Shanghai Zhongshan Hospital clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 648 studies whose lead sponsor is Shanghai Zhongshan Hospital. 289 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.
Keep track of what changes. Save the Shanghai Zhongshan Hospital studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Focus areas
Conditions Shanghai Zhongshan Hospital leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Carcinoma, Hepatocellular61Coronary Artery Disease29Stomach Neoplasms27Coronary Disease17Esophageal and Gastric Varices17Cholangiocarcinoma16Esophageal Squamous Cell Carcinoma15Diabetes Mellitus13Liver Neoplasms13Pancreatic Neoplasms13Adenocarcinoma12Diabetes Mellitus, Type 212Hypertension, Portal12Esophageal Neoplasms11Heart Failure10Hemorrhage10Liver Cirrhosis10Lung Neoplasms10
Studies
Recruiting first, then most recently updated. Showing 50 of 648. Browse all 648 →
- ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight ManagementRecruitingNCT07517042Not applicable
- Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCLRecruitingNCT07012980Phase 2
- A Study on Abnormal Menstrual Bleeding in Chinese Women of Childbearing Age Taking Antithrombotic Drugs After Cardiovascular SurgeryRecruitingNCT07870941
- Sleep and Circadian Rhythm Intervention in ICURecruitingNCT07869901Not applicable
- HOPE-Sepsis: Hemoadsorption Therapy for SepsisNot yet recruitingNCT07865585Not applicable
- Thymalfasin for Immune Recovery in Adults With SepsisRecruitingNCT07866118Not applicable
- Eye-Tracking Communication Tool for Non-verbal ICU PatientsNot yet recruitingNCT07205419Not applicable
- Multicenter Prospective Cohort of Sepsis and ARDS in ChinaRecruitingNCT07863908
- China Aortic Infection and Graft Infection Study: An Ambispective CohortRecruitingNCT07847346
- Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-MakingRecruitingNCT07856017
- Trends and Risk Factors of Adverse Cardiovascular and Cerebrovascular Events After Primary PCIRecruitingNCT07833995
- Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPCNot yet recruitingNCT07833241Phase 2
- AI-Assisted Anaerobic Threshold Interpretation in Cardiopulmonary Exercise TestingNot yet recruitingNCT07833137Not applicable
- Positive- vs Negative-Pressure Extubation in High-Risk PatientsNot yet recruitingNCT07829627Not applicable
- Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver MutationsNot yet recruitingNCT07829744Phase 2
- Physician-Supervised GPT Assistance for Communicating Cardiopulmonary Exercise Test ResultsNot yet recruitingNCT07829731Not applicable
- TEE-Guided Versus CCTA-Guided Preprocedural Imaging for Left Atrial Appendage ClosureRecruitingNCT07815119Not applicable
- OPtimization of Antiplatelet Therapy After the intervenTION of de Novo Coronary Artery Lesions With Drug-Coated BalloonsNot yet recruitingNCT07815106Phase 4
- Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell CarcinomaNot yet recruitingNCT07812467Phase 2
- Biomarker and Mechanism Study of Systemic Therapy in Unresectable HCCNot yet recruitingNCT07786792
- A Multicenter Prospective Study Evaluating the Diagnostic Performance of Femtosecond Laser Label-Free Imaging Combined With Artificial Intelligence for Predicting High-Risk Pathological Features in Lung CancerNot yet recruitingNCT07799038
- A Multicenter, Prospective Study on the Diagnostic Efficacy of Femtosecond Laser Label-Free Imaging Combined With Artificial Intelligence-Assisted Diagnosis for Rapid Diagnosis of Lung Cancer Surgical SpecimensNot yet recruitingNCT07794449
- An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic CancerRecruitingNCT06938282Phase 2
- Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLCRecruitingNCT05987826Phase 2
- Different Acupoint Stimulation for Postoperative Gastrointestinal Dysfunction in Primary Liver Cancer PatientsNot yet recruitingNCT07781176Not applicable
- Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic RegurgitationRecruitingNCT07677410Not applicable
- A Prospective Observational Study Using the FAM-CAMRecruitingNCT07694687
- Accuracy of 3D Electrical Impedance Tomography for Assessing Lung VentilationNot yet recruitingNCT07756086
- Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure PatientsNot yet recruitingNCT07725484Phase 3
- Longitudinal Data Registry of Plasma Cell DyscrasiaRecruitingNCT06760052
- A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).RecruitingNCT07638683Phase 2
- LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or ReplacementNot yet recruitingNCT07733076Not applicable
- Impact of 3D-EIT-Guided Acapella Breathing Training on Lung Ventilation DistributionNot yet recruitingNCT07733843Not applicable
- Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular CarcinomaNot yet recruitingNCT07734857
- QL1706(Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract CancerRecruitingNCT07733115Phase 2
- Evaluate the Diagnostic Efficacy and Safety of INR 202 PET/CT Imaging in Participants With Advanced Solid TumorsNot yet recruitingNCT07727317Not applicable
- The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical StudyNot yet recruitingNCT07724951
- Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With Combination of CTLA-4, PD-1 Antibodies and Bevacizumab in Resectable HCC (Prophet)Not yet recruitingNCT07714317Phase 1/2
- Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)RecruitingNCT06796803Phase 2/3
- AI-Driven Tumor Response Evaluation for Solid TumorsNot yet recruitingNCT07685548
- Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral AgentsRecruitingNCT07307235Phase 4
- HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic CholangiocarcinomaNot yet recruitingNCT07685535Phase 2
- A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal DataRecruitingNCT07561814
- EIT-Guided Visual Feedback During Incentive Spirometry for Postoperative AtelectasisNot yet recruitingNCT07681232Not applicable
- Eye Tracking for Early Identification of Post-ICU Cognitive ImpairmentNot yet recruitingNCT07676864
- Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic CancerRecruitingNCT07529626
- A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese ParticipantsNot yet recruitingNCT07671391Phase 2
- Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial InfarctionNot yet recruitingNCT07621380Phase 4
- Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma PatientsRecruitingNCT07663253
- MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric CancerNot yet recruitingNCT07625735